BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31115573)

  • 21. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
    Yu X; Zhang J; Yang R; Li C
    Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
    Zhu HR; Yu XN; Zhang GC; Shi X; Bilegsaikhan E; Guo HY; Liu LL; Cai Y; Song GQ; Liu TT; Dong L; Janssen HLA; Weng SQ; Wu J; Shen XZ; Zhu JM
    Int J Mol Med; 2019 Nov; 44(5):1844-1854. PubMed ID: 31485608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
    Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
    Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Moyo B; Nicholson SA; Arbuthnot PB
    Virus Res; 2016 Jan; 212():103-13. PubMed ID: 26239319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer.
    Zhang Z; Wang S; Yang F; Meng Z; Liu Y
    Oncol Rep; 2020 Jan; 43(1):55-74. PubMed ID: 31746401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
    Pan YF; Qin T; Feng L; Yu ZJ
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low lncRNA ZNF385D‑AS2 expression and its prognostic significance in liver cancer.
    Zhang Z; Wang S; Liu Y; Meng Z; Chen F
    Oncol Rep; 2019 Sep; 42(3):1110-1124. PubMed ID: 31322274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma.
    Gu J; Zhang X; Miao R; Ma X; Xiang X; Fu Y; Liu C; Niu W; Qu K
    Aging (Albany NY); 2018 Jul; 10(7):1627-1639. PubMed ID: 30018179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
    Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
    Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
    Wang B; Tang D; Zhang Z; Wang Z
    J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology.
    Zhang Q; Matsuura K; Kleiner DE; Zamboni F; Alter HJ; Farci P
    J Transl Med; 2016 Nov; 14(1):328. PubMed ID: 27894309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
    Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
    Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC.
    Wang W; Wang L; Song C; Mu T; Hu J; Feng H
    J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.